Cellect Biotechnology Ltd. [NASDAQ: APOP] jumped around 1.36 points on Wednesday, while shares priced at $4.75 at the close of the session, up 40.12%. The company report on November 20, 2020 that Cellect Biotechnology Reports Third Quarter Financial and Operating Results; Recent Developments Position Company to Accelerate Progress in 2021.
Promising Progress on Clinical Development Progress, Collaborations and Partnering.
Mutually Ended Discussion on Medical Cannabis Commercial and Merger Agreements.
Cellect Biotechnology Ltd. stock is now 119.91% up from its year-to-date (YTD) trading value. APOP Stock saw the intraday high of $4.82 and lowest of $3.41 per share. The company’s 52-week high price is 5.40, which means current price is +125.12% above from all time high which was touched on 02/10/21.
Compared to the average trading volume of 195.48K shares, APOP reached a trading volume of 1657102 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Cellect Biotechnology Ltd. [APOP]?
H.C. Wainwright have made an estimate for Cellect Biotechnology Ltd. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on September 25, 2017.
The Average True Range (ATR) for Cellect Biotechnology Ltd. is set at 0.34 The Price to Book ratio for the last quarter was 6.87.
How has APOP stock performed recently?
Cellect Biotechnology Ltd. [APOP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 42.64. With this latest performance, APOP shares gained by 75.93% in over the last four-week period, additionally plugging by 45.26% over the last 6 months – not to mention a rise of 100.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for APOP stock in for the last two-week period is set at 85.61, with the RSI for the last a single of trading hit 89.63, and the three-weeks RSI is set at 81.76 for Cellect Biotechnology Ltd. [APOP]. The present Moving Average for the last 50 days of trading for this stock 2.65, while it was recorded at 3.62 for the last single week of trading, and 2.62 for the last 200 days.
Cellect Biotechnology Ltd. [APOP]: Deeper insight into the fundamentals
Return on Total Capital for APOP is now -150.45, given the latest momentum, and Return on Invested Capital for the company is -114.81. Return on Equity for this stock declined to -117.62, with Return on Assets sitting at -80.67. When it comes to the capital structure of this company, Cellect Biotechnology Ltd. [APOP] has a Total Debt to Total Equity ratio set at 7.23. Additionally, APOP Total Debt to Total Capital is recorded at 6.74, with Total Debt to Total Assets ending up at 5.03. Long-Term Debt to Equity for the company is recorded at 4.56, with the Long-Term Debt to Total Capital now at 4.26.
Reflecting on the efficiency of the workforce at the company, Cellect Biotechnology Ltd. [APOP] managed to generate an average of -$336,955 per employee.
Earnings analysis for Cellect Biotechnology Ltd. [APOP]
With the latest financial reports released by the company, Cellect Biotechnology Ltd. posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -0.31/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 48.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for APOP.
Insider trade positions for Cellect Biotechnology Ltd. [APOP]
There are presently around $1 million, or 27.16% of APOP stock, in the hands of institutional investors. The top three institutional holders of APOP stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 147,925, which is approximately -33.395% of the company’s market cap and around 8.03% of the total institutional ownership; WEDBUSH SECURITIES INC, holding 39,870 shares of the stock with an approximate value of $0.14 million in APOP stocks shares; and HRT FINANCIAL LP, currently with $90000.0 in APOP stock with ownership of nearly New of the company’s market capitalization.
Positions in Cellect Biotechnology Ltd. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 3 institutional holders increased their position in Cellect Biotechnology Ltd. [NASDAQ:APOP] by around 68,738 shares. Additionally, 4 investors decreased positions by around 76,341 shares, while 0 investors held positions by with 95,554 shares. The mentioned changes placed institutional holdings at 240,633 shares, according to the latest SEC report filing. APOP stock had 2 new institutional investments in for a total of 66,456 shares, while 2 institutional investors sold positions of 1,168 shares during the same period.